2m 2m 2m 2m 2m 2m 2m
ELOXX PHARMACT (ELOX)
NASDAQ
$15.82+$0.07 (+0.42%)
Price as of Sep 11, 2026 7:30 PM EDT- $54.1MMarket Cap
- 1,431,718.18%1-Year Change
- BiotechnologyIndustry
ELOXX PHARMACT (ELOX)
$15.82+$0.07 (+0.42%)
ELOX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.75 | ||
Change | -$0.53 (-3.26%) | ||
Open | $16.74 | ||
High | $17.19 | ||
Low | $15.00 | ||
Previous Close | $16.28 | ||
Volume | 17,169 | ||
30-Day Average Volume | 44,587 | ||
1-Week Change | 5.00% | ||
1-Month Change | -17.88% | ||
1-Year Change | 1,431,718.18% | ||
3-Year Change | -70.84% | ||
5-Year Change | -97.86% | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $63.4M | ||
Market Cap | $54.1M | ||
Enterprise Value | -$5.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$4.8M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $46.4M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -24 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue